Med. Pro Praxi 2006; 4: 164-167 [Interní Med. 2006; 8(5): 214-218]

Současný pohled na nemocného se zvýšeným kardiovaskulárním rizikem

prof. MUDr. Jiří Vítovec CSc1, prof. MUDr. Jindřich Špinar CSc2
1 I. interní kardioangiologická klinika FN u sv. Anny v Brně
2 II. interní klinika FN u sv. Anny LF MU, Brno

Je podán přehled postupů v primární péči u vysoce rizikových nemocných a v sekundární prevenci kardiovaskulárních onemocnění s rizikem vzniku či recidiv postižení srdečně-cévní soustavy. Kromě nefarmakologických postupů je zdůrazněna farmakologická léčba: inhibitory systému renin-angiotenzin – ACE inhibitory a sartany, betablokátory, antiagregační léčba kyselinou acetylosalicylovou s clopidogrelem a podání statinů.

Keywords: inhibitory ACE, sartany, betablokátory, kyselina acetylosalicylová, clopidogrel, statiny

Published: October 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vítovec J, Špinar J. Současný pohled na nemocného se zvýšeným kardiovaskulárním rizikem. Med. praxi. 2006;3(4):164-167.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Arnold JMO, Yusuf S, Young J et al. Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation 2003; 107: 1284-1290. Go to original source... Go to PubMed...
    2. Backer G, Ambrosioni E, Borch-Jonsen K et al. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2003; 24: 1601-1610. Go to original source... Go to PubMed...
    3. Bělohlávek J, Aschermann M. Kyselina acetylsalicylová a ACE inhibitory u kardiaků - fenomén pejska a kočičky? Vnitřní Lék 2002; 48: 695-697.
    4. Bertrand ME, Simoons ML, Fox KA et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2002; 23: 1809-1840. Go to original source... Go to PubMed...
    5. Bhat DL, Keith AA, Fox MB et al. For the CHARISMA study investigators: Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006; 354: published at www.nejm.org on Mar 12, 2006. Go to PubMed...
    6. Bosch J. Extended follow-up of the ramipril component of the Heart Outcomes Prevention Evaluation (HOPE-TOO). Presented at the ESC Congress 2003; Vienna, Austria. Clinical Trial Update III Hypertension/Prevention, Presentation No 3711.

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.